Pfizer Inc.
ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH
Last updated:
Abstract:
Pulmonary hypertension and related diseases, like pulmonary arterial hypertension, can be treated by administering an effective dose of a CDK inhibitor, including palbociclib, 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2yl]amino}p- yrido[2,3-d]pyrimidin-7(8H)-one, or pharmaceutically acceptable salt thereof.
Status:
Application
Type:
Utility
Filling date:
4 Nov 2020
Issue date:
24 Jun 2021